Executive Director, New Product Planning
Immunovant
This listing was originally posted on Immunovant's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moImmunovant, Inc. is a clinical-stage biopharmaceutical company dedicated to enabling normal lives for people with autoimmune diseases. As trailblazers in FcRn inhibitor technology, the Company is boldly developing innovative therapies for a range of debilitating autoimmune diseases with significant unmet patient needs.
The Role:
The Executive Director of New Product Planning is responsible for new product opportunity assessments and the commercial strategy for lifecycle indications of IMVT-1402. Reporting to the Chief Strategy Officer, this position leads commercial strategy and market development efforts for new products and follow-on indications from ideation through handoff to the launch team for build-out approximately 24 months pre-launch. Leading their team and partnering with commercial, the Executive Director will work to identify and prioritize potential new indications and manage commercial strategy for indications in development.
Key Responsibilities:
New Product Planning
Requirements:
Work Environment:
Compensation is based on a number of factors, including market location, and may vary depending on job-related knowledge, skills, and experience. Equity and other forms of compensation may be provided as part of a total compensation package, in addition to a full range of medical, dental, vision, 401k, and other benefits, including unlimited paid time off and parental leave.
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Immunovant?
Help others prepare — share your experience anonymously.
BIOTECHNOLOGY
Monoclonal Antibody
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo